Dr. Julie Lecomte
ActiveDr. Julie Lecomte has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €130k and a net result of €53k. Equity is growing by ~78.5% per year across the filed fiscal years. Its solvency ranks better than 70% of 16511 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
95
/ 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency100▲+18
Growth78=
Track record82
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €12k at 30 days only on tighter terms
Liquidity ample (current ratio 12.14 against 3.15 in 2024; short-term debt: 6.4% and cash: 25.7% of total assets), and 19.1% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
80.9%
Return on assets
33.1%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 27-04-2026, 95 days ahead of the deadline.
NBB · 3 filingsDeviation from the deadline
2025
95 d early
2024
16 d early
2023
30 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
21-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Source amounts without an identifiable currency are assumed to be EUR.
Equity
€130k▲ 69.3%
2024 · €77k
2023: €9k
2024: €77k
2023 → 2025
Total assets
€160k▲ 19.6%
2024 · €134k
2023: €18k
2024: €134k
2023 → 2025
Net result
€53k▼ 22.0%
2024 · €68k
2023: €9k
2024: €68k
2023 → 2025
Working capital
€114k▲ 87.0%
2024 · €61k
2023: €10k
2024: €61k
2023 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line202320242025Trend
Equity€9k-€77k▲ 716%€130k▲ 69.3%
Operating result€11k-€86k▲ 674%€67k▼ 21.7%
Net result€9k-€68k▲ 680%€53k▼ 22.0%
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 22% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €160k
Fixed assets
€37k▼ 18.8%
Current assets
€124k▲ 39.1%
Equity and liabilities €160k
Equity
€130k▲ 69.3%
Debt
€31k▼ 46.7%
The debt ratio falls from 42.8% to 19.1%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€78k▼
2024 · €90k
Cash flow
€63k▼
2024 · €73k
Solvency
80.9%▲
2024 · 57.2%
Current ratio
12.14▲
2024 · 3.15
Quick ratio
12.14▲
2024 · 3.15
Debt / equity
0.24▼
2024 · 0.75
ROE
40.9%▼
2024 · 88.8%
ROA
33.1%▼
2024 · 50.8%
Interest coverage
1724.06▼
2024 · 2035.57
Debt
€31k▼
2024 · €57k
Debt ≤ 1 year
€10k▼
2024 · €28k
Debt > 1 year
€20k▼
2024 · €29k
Income taxes
€14k▼
2024 · €18k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€134k€160k▲
Fixed assets21/28€45k€37k▼
Tangible fixed assets22/27€45k€37k▼
Plant, machinery and equipment23-€2k
Furniture and vehicles24€45k€35k▼
Current assets29/58€89k€124k▲
Amounts receivable within one year40/41€9k€11k▲
Trade receivables40€3k€11k▲
Other amounts receivable41€6k€0▼
Current investments50/53-€70k
Cash at bank and in hand54/58€78k€41k▼
Deferred charges and accrued income490/1€1k€1k▼
Equity and liabilities
Total equity and liabilities10/49€134k€160k▲
Equity10/15€77k€130k▲
Contributions10/11€2k€2k=
Reserves13€75k€128k▲
Distributable reserves133€75k€128k▲
Profit (loss) carried forward14-€0
Amounts payable17/49€57k€31k▼
Amounts payable after more than one year17€29k€20k▼
Financial debts170/4€29k€20k▼
Amounts payable within one year42/48€28k€10k▼
Current portion of amounts payable after more than one year42€6k€9k▲
Trade debts44€2k€788▼
Suppliers440/4€2k€788▼
Taxes, remuneration and social security45€18k€115▼
Taxes450/3€18k€115▼
Other amounts payable47/48€3k€549▼
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€4k€10k▲
Other operating charges640/8-€120
Gross operating margin9900€90k€78k▼
Operating profit (loss)9901€86k€67k▼
Financial charges65/66B€44€45▲
Recurring financial charges65€44€45▲
Profit (loss) for the period before taxes9903€86k€67k▼
Income taxes67/77€18k€14k▼
Profit (loss) for the period9904€68k€53k▼
Profit (loss) for the period to be appropriated9905€68k€53k▼
Appropriation of the result
Profit (loss) to be appropriated9906€68k€53k▼
Transfer to equity691/2€67k€53k▼
To other reserves6921€67k€53k▼
Profit to be distributed694/7€833€0▼
Return on contributions (dividend)694€833€0▼
The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
27-04
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Liquidity quadruplescurrent ratio 12.14
Current ratio from 3.15 to 12.14; short-term debt falls from €28k to €10k.
31-12
Financial
Equity above €100kEq €130k ▲69.3%
3 profitable years in a row build equity to €130k.
15-07
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
31-12
Financial
Highest result since 2023net €68k ▲680%
Operating result €86k, net result €68k, both a record.
01-07
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Brecht · 1 establishment unit since 2023
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Cambeenbos laan A 122960 BrechtGround area
1,056 m²
Building footprint
182 m²
Volume, LiDAR
804 m³
Parcel 11009M0007/00B004, Flanders · tallest building 6.5 m, ±1 floor. Linked by address, not a title deed.
1 establishment unit
Dr. Julie Lecomte
since 20232.351.140.933
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11009M0007/00B004 | Flanders | 1,056 m² | 1 · 182 m² | 6.5 m · 1 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Maison Médicale Les Peupliers
BE 0751.774.942
Ukkel · Eq €130k
NOVAMED GROUP
BE 1010.684.768
Brussel · Eq €130k
Fanny de Medici
BE 0803.779.513
Gembloux · Eq €130k
GEMAMEDIC
BE 0885.952.567
Sint-Pieters-Woluwe · Eq €130k
DOCTEUR FLORENCE JAMAR
BE 0775.720.678
Namur · Eq €130k
Of 9,124 companies in sector 86210 we hold annual accounts for 6,337. 5,426 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded20-10-2023
Fiscal year end31-12
Activities, NACEBEL
86210General medical practice
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 3 filingsAddress and cadastre registers
Data from official sources, last processed on 20-09-2026. Scores and ratios are computed by Checked and are not a credit decision.